Home - Boston Life Sciences Times

LATEST ARTICLES

Pharma

Tahoe, Alloy to Launch Joint Venture Focused on First-in-Class ADCs for Hard-to-Treat Cancers

Life Sciences Times - January 13, 20260

Venture Capital

Nuclera Raises Series C Funding to $87 Million to Expand Antibody Engineering Platform

Life Sciences Times - January 13, 20260

Technology

Thermo Fisher Scientific, NVIDIA Partner to Apply AI Across Scientific Instrumentation and Laboratory Automation

Life Sciences Times - January 13, 20260

Pharma

FDA Accepts Pimicotinib NDA for Treatment of Rare Joint Tumor

Life Sciences Times - January 13, 20260

Pharma

FDA Sets August 30, 2026 PDUFA Date for PharmaEssentia sBLA in Essential Thrombocythemia

Life Sciences Times - January 13, 20260

Technology

Massachusetts Leaders Gather at State House for AI Ethics and Trust Roundtable

Life Sciences Times - January 13, 20260

Real Estate

BioMed Realty, TransMedics Finalize 498,000-Square-Foot Lease at Assembly Innovation Park

Life Sciences Times - January 13, 20260

Biotech

Aurora Therapeutics Launches With $16 Million Seed Round to Scale Personalized Gene Editing for Rare Diseases

Life Sciences Times - January 9, 20260

Biotech

GC Therapeutics Names Kate Haviland Board Chair, Advances Cell Therapy Pipeline and Platform

Life Sciences Times - January 9, 20260

Venture Capital

MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial

Life Sciences Times - January 9, 20260

1...484950...831 Page 49 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Study Maps Microplastics Throughout the Body, Revealing Organ-Level Effects

NeuroPace Reports Strong Long-Term Results for Epilepsy Device, Expands Clinical Evidence

POPULAR CATEGORY

ABOUT US

FOLLOW US